Tumor suppressor CLCA1 inhibits angiogenesis via TGFB1/SMAD/VEGF cascade and sensitizes hepatocellular carcinoma cells to Sorafenib
Authors:
- 23 May 2023
- journal article
- research article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 56 (1) , 176-186
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation Project of Chongqing
- National Natural Science Foundation of China (81872380, 82172619)
- Natural Science Foundation of Chongqing Municipality (CSTC2021jscx-gksb-N0023, cstc2019jcjy-msxmX0861, cstc2020jcyj-bshX0025)
- Chongqing Graduate Student Research Innovation Project (CYB21168)
This publication has 53 references indexed in Scilit:
- Transforming growth factor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocellular carcinomaLaboratory Investigation, 2012
- Inhibition of Transforming Growth Factor β Receptor I Kinase Blocks Hepatocellular Carcinoma Growth Through Neo-angiogenesis Regulation†Hepatology, 2009
- Modes of resistance to anti-angiogenic therapyNature Reviews Cancer, 2008
- Smad3 Is Overexpressed in Advanced Human Prostate Cancer and Necessary for Progressive Growth of Prostate Cancer Cells in Nude MiceClinical Cancer Research, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- Smad7 induces tumorigenicity by blocking TGF-β-induced growth inhibition and apoptosisExperimental Cell Research, 2005
- Angiogenesis and hepatocellular carcinomaJournal of Hepatology, 2004
- TGF-β SIGNAL TRANSDUCTIONAnnual Review of Biochemistry, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Positive correlation of plasma transforming growth factor-β1 levels with tumor vascularity in hepatocellular carcinomaCancer Letters, 1995